Response Genetics' Q1 Revenues Increase 40 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Molecular diagnostics company Response Genetics today reported a 40 percent increase year over year in its first-quarter revenues.

The Los Angeles-based company said that for the three months ended March 31, revenues rose to $5.6 million from $4.0 million. Revenues from its pharmaceutical clients increased 137 percent year over year, while revenues generated by ResponseDX products rose 8 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.